Geneos Wealth Management Inc. Sage Therapeutics, Inc. Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 08, 2021	SELL	$54.88 - $79.29 $6,860 - $9,911	-125 Closed	0 $0
Q1 2021 Jun 17, 2021	SELL	$70.65 - $96.76 $26,493 - $36,285	-375 Reduced 75.0%	125 $9,000
Q4 2020 May 19, 2021	BUY	$58.41 - $89.06 $29,205 - $44,530	500 New	500 $36,000
Q2 2016 Sep 07, 2021	SELL	N/A	-145 Closed	0 $0
Q1 2016 Sep 07, 2021	BUY	N/A	145	145 $4,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.